Health/Life Sciences Marketers Prioritized Event, Social Media Spend Over Email In 2022

Providers in the health or life sciences industry increased their marketing budgets last year, according to Health & Life Sciences Marketing Trends, a study by Scorr Marketing.

Of the companies polled, 52% upped their spending on trade shows/events/booths, 41% on website/apps, interactive development and 37% on social media.  

In addition, 81% of drug development services companies developed an annual marketing plan. But that was down from 87% in 2021. 

And 45% developed an annual public relations/communications plan, versus 54% in the prior year. But 78% regularly seek feedback from clients on ways to improve, up from 73% in 2021. 

Email marketing was not among the leading channels in terms of either spend or effectiveness. The respondents gave these grades to different channels, 5 being the highest:

  • Webinars — 3.84 
  • Case studies — 3.83
  • White papers — 3.74 
  • Social media — 3.63 
  • Video — 3.57 
  • Online presentations — 3.44 
  • Digital advertising — 3.43 
  • Infographics — 3.27
  • Paid search — 3.25
  • Email marketing — 3.23 
  • Blogs — 3.20
  • Podcasts — 3
  • E-books — 2.88 

Overall, 72% of companies use social media advertising, rating the platforms as follows:

  • LinkedIn — 4.26 
  • YouTube — 3.11 
  • Twitter — 3.01 
  • Vimeo — 2.50 
  • Facebook — 2.37 
  • Instagram — 2.13 
  • WhatsApp — 1.89
  • Tik Tok — 1.61
  • Snapchat — 1.45
  • Pinterest — 1.40 

Scorr surveyed 123 executives in the health/life sciences industry last summer. Of these, 26% were:  

  • Spomsors (the biotech, medical device, or pharmaceutical company that drugs and holds patents for approved drugs) — 26%
  • CROs (contact research organization that manages studies or functions within a study on behalf of sponsors) — 25% 
  • Software/Tech (a company that provides a platform to help process the huge amounts of data generated and collected during the drug development process) — 15%
  • CDMO (Contract development and manufacturing organization, able to conduct both the development and manufacturing of a drug)/CMOs (contract manufacturing organization, an entity that manages studies or functions within a study on behalf of sponsors) — 15%
  • Other — 13% 
  • Consultants — 3

 

 

Next story loading loading..